• About Us
    • Fact Checking Policy
    • Ownership & funding information
    • Volunteer
  • Subscribe
  • Letter submission
    • Submissions Policy
  • Contact Us
The Online Citizen Asia
  • Opinion
    • Editorial
    • Commentaries
    • Letters
    • Comments
  • Current Affairs
    • Singapore
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Arts & Culture
    • Consumer Watch
    • NGO
    • Lifestyle
    • Travel
  • Politics
    • Civil Society
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Letters
    • Comments
  • Current Affairs
    • Singapore
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Arts & Culture
    • Consumer Watch
    • NGO
    • Lifestyle
    • Travel
  • Politics
    • Civil Society
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
No Result
View All Result
The Online Citizen Asia
No Result
View All Result

HSA recalls three brands of Losartan medicines from Hetero Labs Ltd

by Neyla Zannia
29/03/2019
in Current Affairs, Health
Reading Time: 3 mins read
0

Losartas 100mg (Source: HSA).

The Health Sciences Authority (HSA) has recalled Hyperten Tablet, Losagen Tablet, and Losartas Tablet from Hetero Labs Ltd as they were found to contain trace amounts of a nitrosamine impurity, N-nitroso-N-methyl-4-aminobutyric acid (NMBA), which are above internationally acceptable levels.

In its press release, HSA advised patients not to stop treatment on their own as there is no immediate health risk associated with taking the affected medicines. However, healthcare professionals are encouraged to review the medicine and treatment plans of their patients.

In a separate press release, the Ministry of Health (MOH) stated that about 137,000 patients in Singapore are using the three recalled brands of losartan medicine. Of these, about 130,000 patients have been prescribed Losartas at public healthcare institutions.

The authority noted that not all losartan medicines are affected by this recall, saying that only three out of the ten losartan products in Singapore contain unacceptable levels of nitrosamine impurity.

Hyperten 50mg (Source: HSA).
Hyperten 100mg (Source: HSA).
Losagen 50mg (Source: HSA).
Losagen 100mg (Source: HSA).
Losartas 100mg (Source: HSA).
Losartas 50mg (Source: HSA).

According to the authority, losartan belongs to a class of medicines called angiotensin II receptor blockers (ARBs), which are used to treat high blood pressure, also known as hypertension.

In addition to the three recalled brands, there are seven other brands of losartan medicines marketed in Singapore and these seven brands have been tested by HSA and do not contain NMBA:

The authority stated that since June 2018, several ARB medicines have been recalled overseas due to the presence of two other nitrosamine impurities, N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA).

HSA noted that it had tested the locally marketed ARB medicines and none of them was found to contain unacceptable levels of the two impurities.

In end-June 2018, several valsartan-containing medicines were recalled overseas due to the presence of NDMA. Based on HSA’s checks, none of valsartan products marketed in Singapore were affected.

Meanwhile, in September 2018, several overseas regulatory agencies recalled affected ARBs due to the presence of NDEA. HSA had tested the ARBs marketed in Singapore and none were found to contain unacceptable levels of these impurities.

Since November 2018, HSA stressed that it has required companies to test for these impurities in their products and comply with international standards, to ensure the continued quality of the products imported into Singapore.

Since end-February 2019, several losartan medicines were recalled overseas due to the presence of NMBA.

According to the authority, all locally marketed losartan products have been tested for the presence of the new NMBA impurity. By testing all brands of losartan medicines available locally beyond Hetero Labs products, HSA said that it is able to advise which brands did not contain NMBA, and help healthcare professionals decide on suitable alternatives for patients in place of the recalled brands.

HSA said that the risks of trace amounts of NMBA are associated with long term exposure. Sudden stopping of the medicines can pose a greater and more immediate risk to the patient’s health.

Professor Ding Zee Pin, Cardiologist in the National Heart Centre Singapore and HSA’s Expert Panel on Nitrosamines advises: “There is no immediate health risk associated with taking the affected medicines, and patients are advised not to stop or change treatment on their own. As losartan is used to treat high blood pressure, stopping the medicine without replacement of other equivalent medication can increase the risk of poor control of blood pressure.”

HSA advises consumers who are taking the three affected brands of losartan medicines to do the following:

  • Do not stop taking the medicines on your own until you have been provided with a replacement brand of losartan or a different medicine by your healthcare provider.
  • Discuss your medication and treatment plan with your healthcare provider.  Your healthcare provider has been advised to make arrangements to review and provide you with alternatives or other therapies.
  • Only three of the ten losartan products in Singapore – Hyperten, Losagen and Losartas – contain the nitrosamine impurity. Consult your healthcare provider if you are unsure if you are taking an affected brand.
  • Consumers can contact the HSA hotline at Tel: 6866 3538 or email: [email protected] if you have further enquiries.
For just US$7.50 a month, sign up as a subscriber on The Online Citizen Asia (and enjoy ads-free experience on our site) to support our mission to transform TOC into an alternative mainstream press.

Related Posts

Hong Kong’s largest national security trial opens
AFP

Hong Kong’s largest national security trial opens

06/02/2023
Venerable Master Hsing Yun passed away at age 97
Arts & Culture

Venerable Master Hsing Yun passed away at age 97

06/02/2023
No response from Josephine Teo on whether Mediacorp has been instructed to stop coverage of SMT circulation scandal
Singapore

No response from Josephine Teo over alleged blackout of coverage by Mediacorp over SMT circulation scandal

06/02/2023
Earthquake victims stage demonstration after Cianjur Regency Govt cancels temporary housing assistance of US$68 per family
Indonesia

Earthquake victims stage demonstration after Cianjur Regency Govt cancels temporary housing assistance of US$68 per family

06/02/2023
The uncomfortable past appointments by PAP members for CPIB in Keppel’s corruption scandal
Singapore

The uncomfortable past appointments by PAP members for CPIB in Keppel’s corruption scandal

06/02/2023
Not the first time, Tong Chong Heong, former KOM senior executive, was involved in corruption at Keppel
People

Not the first time, Tong Chong Heong, former KOM senior executive, was involved in corruption at Keppel

06/02/2023
Subscribe
Connect withD
Login
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
Notify of
Connect withD
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
0 Comments
Inline Feedbacks
View all comments

Latest posts

Hong Kong’s largest national security trial opens

Hong Kong’s largest national security trial opens

06/02/2023
Venerable Master Hsing Yun passed away at age 97

Venerable Master Hsing Yun passed away at age 97

06/02/2023
No response from Josephine Teo on whether Mediacorp has been instructed to stop coverage of SMT circulation scandal

No response from Josephine Teo over alleged blackout of coverage by Mediacorp over SMT circulation scandal

06/02/2023
Earthquake victims stage demonstration after Cianjur Regency Govt cancels temporary housing assistance of US$68 per family

Earthquake victims stage demonstration after Cianjur Regency Govt cancels temporary housing assistance of US$68 per family

06/02/2023
The uncomfortable past appointments by PAP members for CPIB in Keppel’s corruption scandal

The uncomfortable past appointments by PAP members for CPIB in Keppel’s corruption scandal

06/02/2023
Not the first time, Tong Chong Heong, former KOM senior executive, was involved in corruption at Keppel

Not the first time, Tong Chong Heong, former KOM senior executive, was involved in corruption at Keppel

06/02/2023
Temasek and GIC reportedly in talks with Adani Group accused of “brazen” market manipulation and accounting fraud

Adani stock rout raises questions about India’s credibility even as S’pore becomes #1 investor in India

06/02/2023
Sixteen killed in China highway pile-up

Sixteen killed in China highway pile-up

05/02/2023

Trending posts

Former Singaporean shares change of life in Australia with annual pay of S$80,000 as a plumber

Former Singaporean shares change of life in Australia with annual pay of S$80,000 as a plumber

by Yee Loon
30/01/2023
25

...

Cognizant India transfers staff to work in Singapore as recently as this year

Local IT grads can’t find jobs while engineers constantly transferred from India to work in SG under CECA

by Correspondent
05/02/2023
49

...

They have done a fine job of confusing us about the jobs situation

They have done a fine job of confusing us about the jobs situation

by Augustine Low
01/02/2023
47

...

Adani’s brother runs SG company and registers as director with local ID

Adani’s brother runs SG company and registers as director with local ID

by Correspondent
03/02/2023
26

...

Excessively charging for an essential need, and calling it affordable because people still can pay for it?

by Terry Xu
31/01/2023
40

...

Singapore Law Watch removes commentary on CPIB’s decision to not prosecute former Keppel executives

Singapore Law Watch removes commentary on CPIB’s decision to not prosecute former Keppel executives

by The Online Citizen
02/02/2023
19

...

March 2019
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
« Feb   Apr »

The Online Citizen is a regional online publication based in Taiwan and formerly Singapore’s longest-running independent online media platform.

Navigation

  • Editorial
  • Commentaries
  • Opinion
  • Politics
  • Community

Support

  • Contact Us
  • Letter submission
  • Membership subscription

Follow Us

  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Fact Checking Policy
  • Privacy Policy

© 2022 - 2023 The Online Citizen Asia

No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Comments
  • Current Affairs
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Civil Society
    • Arts & Culture
    • Consumer Watch
    • NGO
  • Politics
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
  • Lifestyle
    • Travel
  • Subscribers login

© 2022 - 2023 The Online Citizen Asia

wpDiscuz